#news #biotech AstraZeneca, after years of delays and spiraling costs, opens Cambridge R&D site. Will the bet pay off?

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca, after years of delays and spiraling costs, opens Cambridge R&D site. Will the bet pay off? .AstraZeneca, after years of delays and spiraling costs, opens Cambridge R&D site. Will the bet pay off?
ntaylor
Tue, 11/23/2021 – 05:06

from FierceBiotech: Biotech https://ift.tt/3FJcYL0